Literature DB >> 15049106

[Seroprevalence of human T cell lymphotropic virus infection and associated factors of risk in blood donors of Rio Branco city, AC, Brazil (1998-2001)].

Denise Duizit Colin1, Luiz Carlos Alcântara Júnior, Fred Luciano Neves Santos, Rita Uchôa, José Tavares-Neto.   

Abstract

Between December 1998 and March 2001, for each HTLV-I/II seropositive blood donor (ELISA, Abbott), two HTLV-I/II seronegative blood donors were also chosen. The blood samples were re-tested by ELISA (Murex), and those seropositives were also tested by Western Blot and PCR. Of the 11, 121 blood samples, 73 (0.66%) were positives (Abbott), but only 12 (0.11%) remained positives (Murex), whereas the 146 seronegatives were confirmed, even though the concordance index between these two ELISA tests was hopeless. The Western Blot confirmed the twelve blood samples as seropositives: 8 (0.07%) HTLV-I; two (0.02%) HTLV-II and two (0.02%) indeterminate, being by PCR, one HTLV-I and the other HTLV-II. Concluding, in this Western Amazon population the HTLV-I/II seroprevalence was too low, in spite of the greater prevalence of HTLV-II expected due to a great indigenous racial mixture.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15049106     DOI: 10.1590/s0037-86822003000600006

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  2 in total

Review 1.  The challenge of describing the epidemiology of HTLV in the Amazon region of Brazil.

Authors:  Ricardo Ishak; Marluísa de Oliveira Guimarães Ishak; Antonio Carlos R Vallinoto
Journal:  Retrovirology       Date:  2020-02-14       Impact factor: 4.602

2.  Seroprevalence of HTLV-1/2 among blood donors in the state of Maranhão, Brazil.

Authors:  Graça Maria de Castro Viana; Maria do Desterro Soares Brandão Nascimento; Rodrigo Artur Souza de Oliveira; Alessandro Carvalho Dos Santos; Carolina de Souza Galvão; Marcos Antonio Custódio Neto da Silva
Journal:  Rev Bras Hematol Hemoter       Date:  2014
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.